GB:0RN4 Stock Latest News
Company AnnouncementsOncopeptides Boosts Capital Base with Directed Share Issue to Institutional Investors2d ago
Company AnnouncementsOncopeptides to present Q3 2026 results in investor webcast3d ago
Company AnnouncementsOncopeptides Raises SEK 100 Million in Discounted Directed Share Issue to Fund Glioblastoma Push2w ago
Company AnnouncementsOncopeptides Seeks SEK 100m in Directed Share Issue to Accelerate Glioblastoma Program2w ago
Company AnnouncementsOncopeptides to Brief Investors After Positive Glioblastoma Study Data3w ago
Company AnnouncementsOncopeptides Reports Breakthrough Blood-Brain Barrier Data in Glioblastoma Study3w agoCompany AnnouncementsOncopeptides earns EANO poster nod as PDC platform pushes into glioblastoma1M ago
- Company AnnouncementsOncopeptides Wins EMA Backing to Move Pepaxti Into Third-Line Myeloma Use1M ago
Company AnnouncementsOncopeptides AB Earnings Call Highlights Growth Momentum1M ago- Company AnnouncementsOncopeptides lifts Q2 sales 62% and moves to double Pepaxti market in Europe2M ago
- Company AnnouncementsOncopeptides to Present Q2 2026 Results as Oncology Commercialization Expands2M ago
Company AnnouncementsOncopeptides Secures Slovenian List Price for Pepaxti in First CEE Expansion Step2M agoCompany AnnouncementsOncopeptides Updates Share and Vote Structure After Incentive Share Conversion4M ago
- Company AnnouncementsOncopeptides seeks EMA approval to move Pepaxti into earlier-line multiple myeloma treatment4M ago
- Company AnnouncementsOncopeptides launches German real-world study to bolster Pepaxti’s myeloma profile4M ago
- Company AnnouncementsOncopeptides to spotlight Pepaxti data and PDC strategy at EHA 20265M ago
- Company AnnouncementsOncopeptides Accelerates CEE Expansion for Pepaxti via Exclusive Salus Distribution Deal5M ago
Company AnnouncementsOncopeptides AGM Backs Incentive Schemes and Expands Capital-Raising Mandate5M ago
Company AnnouncementsOncopeptides’ Pepaxti Shows Strong Phase 2 Data in Myeloma Patients With Renal Impairment5M ago
Company AnnouncementsOncopeptides Wins Norwegian Green Light for Pioneering Glioblastoma Trial5M ago